Yuxian He

17.1k total citations · 4 hit papers
153 papers, 11.9k citations indexed

About

Yuxian He is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Yuxian He has authored 153 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Infectious Diseases, 76 papers in Virology and 34 papers in Immunology. Recurrent topics in Yuxian He's work include HIV Research and Treatment (76 papers), HIV/AIDS drug development and treatment (59 papers) and SARS-CoV-2 and COVID-19 Research (48 papers). Yuxian He is often cited by papers focused on HIV Research and Treatment (76 papers), HIV/AIDS drug development and treatment (59 papers) and SARS-CoV-2 and COVID-19 Research (48 papers). Yuxian He collaborates with scholars based in China, United States and Hong Kong. Yuxian He's co-authors include Shibo Jiang, Shuwen Liu, Yusen Zhou, Lanying Du, Bo-Jian Zheng, Huihui Chong, Hong Lü, Asim K. Debnath, Yuanmei Zhu and Kwok‐Yung Yuen and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Yuxian He

148 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China

2003 1.7k citations Yuxian He, Kwok‐Yung Yuen et al. profile →
The spike protein of SARS-CoV — a target for vaccine and therapeutic development

2009 1.2k citations Lanying Du, Yuxian He et al. profile →
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

2011 804 citations Yuxian He et al. Journal of Virology profile →
Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy

1999 691 citations Yuxian He et al. profile →

Peers

Countries citing papers authored by Yuxian He

Since Specialization

Citations

This map shows the geographic impact of Yuxian He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxian He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxian He more than expected).

Fields of papers citing papers by Yuxian He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxian He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxian He. The network helps show where Yuxian He may publish in the future.

Co-authorship network of co-authors of Yuxian He

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxian He. A scholar is included among the top collaborators of Yuxian He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxian He. Yuxian He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial 2025 ·Nature Communications ·Yeming Wang, Lianhan Shang, (unknown), (unknown), (unknown), Ke Hu, Yingli He, Guangming Li, Jie Zhai, (unknown), (unknown), Jun Wang, Yan Li, Bin Liu, (unknown), Yuxian He, Chen Wang, Bin Cao	0
2	Structural characterization of HIV fusion inhibitor LP-98: Insights into antiviral and resistance mechanisms 2025 ·Antiviral Research ·Nian Liu, Yuanmei Zhu, Huihui Chong, Sheng Cui, Yuxian He	1
3	Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure 2024 ·Microbes and Infection ·(unknown), Xiaohui Ding, Yuanmei Zhu, Huihui Chong, Yuxian He	4
4	Development of lipopeptide-based HIV-1/2 fusion inhibitors targeting the gp41 pocket site with a new design strategy 2024 ·Antiviral Research ·(unknown), Yuanmei Zhu, (unknown), Huihui Chong, Yuxian He	2
5	Investigating the uncertain causal link between gut microbiota and glaucoma: A genetic correlation and Mendelian randomisation study 2024 ·Clinical and Experimental Ophthalmology ·Jiayong Li, (unknown), (unknown), Yuxian He, Mingkai Lin, Wei Wang, Shicheng Guo, Chao Tang, (unknown), Xinbo Gao	5
6	Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides 2022 ·Antiviral Research ·Yuanmei Zhu, Yue Hu, Nian Liu, Huihui Chong, Yuxian He	12
7	Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice 2021 ·Cellular and Molecular Immunology ·Xiaoxiao Jin, Yan Ding, Shihui Sun, Xinyi Wang, (unknown), Xiaotao Liu, Miaomiao Li, (unknown), Anran Shen, (unknown), Bi‐Cheng Liu, Jianqiong Zhang, Jian Li, Yi Yang, Haibo Qiu, Chuanlai Shen, Yuxian He, Guangyu Zhao	25
8	Safety Assessment of Microbicide 2P23 on the Rectal and Vaginal Microbiota and Its Antiviral Activity on HIV Infection 2021 ·Frontiers in Immunology ·(unknown), Rui Fu, Zheng‐Xiang Li, Ji Wang, Yuxian He	6
9	Two M-T hook residues greatly improve the antiviral activity and resistance profile of the HIV-1 fusion inhibitor SC29EK 2014 ·Retrovirology ·Huihui Chong, Zonglin Qiu, (unknown), Yuanyuan Qiao, (unknown), Yuxian He	24
10	Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains 2013 ·Journal of Virology ·Weizao Chen, Yang Feng, Ponraj Prabakaran, Tianlei Ying, Yanping Wang, (unknown), Camila Macedo, Zhongyu Zhu, Yuxian He, Victoria R. Polonis, Dimiter S. Dimitrov	54
11	The NS1 protein of influenza a virus interacts with heat shock protein Hsp90 in human alveolar basal epithelial cells: Implication for virus-induced apoptosis 2011 ·Virology Journal ·Chuanfu Zhang, Yutao Yang, Xiaowei Zhou, Zhixin Yang, Xuelin Liu, Zhiliang Cao, Hongbin Song, Yuxian He, Peitang Huang	39
12	A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity 2010 ·Viral Immunology ·Lanying Du, Guangyu Zhao, Chris Chan, Lin Li, Yuxian He, Yusen Zhou, Bo‐Jian Zheng, Shibo Jiang	38
13	Sodium-dependent Glucose Transporter Was Involved in Salidroside Absorption in Intestine of Rats 2009 ·Chinese Journal of Natural Medicines ·Yuxian He, Xiaodong Liu, Xinting Wang, Xiang Liu, Guangji Wang, Lin Xie	5
14	Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity 2009 ·Virology ·Lanying Du, Guangyu Zhao, Chris Chan, Shihui Sun, Min Chen, Zhonghua Liu, Hongxiang Guo, Yuxian He, Yusen Zhou, Bo‐Jian Zheng, Shibo Jiang	100
15	Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection 2008 ·Vaccine ·Lanying Du, Guangyu Zhao, Yongping Lin, Chris Chan, Yuxian He, Shibo Jiang, Changyou Wu, Dong‐Yan Jin, Kwok‐Yung Yuen, Yusen Zhou, Bo‐Jian Zheng	69
16	Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies 2005 ·The Journal of Immunology ·Yuxian He, Hong Lü, (unknown), Yusen Zhou, Shibo Jiang	189
17	Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation 2005 ·European Journal of Immunology ·Michael Tuen, Maria Luisa Visciano, Peter Chien, Sandra Cohen, (unknown), James E. Robinson, Yuxian He, Abraham Pinter, Miroslaw K. Górny, Catarina E. Hioe	24
18	Identification of N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4 2005 ·Virology ·Qian Zhao, Liying Ma, Shibo Jiang, Hong Lü, Shuwen Liu, Yuxian He, N. Strick, Nouri Neamati, Asim K. Debnath	177
19	Vaccine Design for Severe Acute Respiratory Syndrome Coronavirus 2005 ·Viral Immunology ·Yuxian He, Shibo Jiang	29
20	Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity Against HIV-1 from Transgenic Mice Expressing Human Ig Loci 2002 ·The Journal of Immunology ·Yuxian He, William Honnen, Chavdar Krachmarov, (unknown), Samuel C. Kayman, José R. F. Corvalán, Abraham Pinter	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact